Related Experiment Video

Updated: Feb 8, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
13:00

Studying Wnt Signaling During Patterning of Conducting Airways

Published on: October 16, 2016

7.8K

Targeting Wnt signaling pseudokinases in hematological cancers

Hanna Karvonen1,2, Robert Perttilä1,2, Wilhelmiina Niininen1,2

  • 1BioMediTech Institute, University of Tampere, Tampere, Finland.

European Journal of Haematology
|July 11, 2018
PubMed

Insights

Targeting pseudokinases like ROR1, PTK7, and RYK offers a promising therapeutic strategy for hematological malignancies. Understanding their molecular mechanisms is key to developing effective cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • Pseudokinases, particularly from the receptor tyrosine kinase family, are implicated in cancer progression, including invasion, metastasis, and drug resistance.
  • Receptor Tyr kinase-like orphan receptors (RORs), protein Tyr kinase 7 (PTK7), and receptor-like Tyr kinase (RYK) are key Wnt signaling receptors involved in cellular functions like migration and polarization.
  • Recent advancements have enhanced understanding of pseudokinase structure-function relationships and signaling networks.

Purpose of the Study:

  • To review the molecular mechanisms of ROR1, PTK7, and RYK.
  • To explore targeted therapies for these pseudokinases in the context of hematological malignancies.
  • To highlight their therapeutic potential in cancer treatment.

Main Methods:

  • Literature review of recent studies on pseudokinases ROR1, PTK7, and RYK.
  • Analysis of molecular mechanisms governing their signaling pathways.
  • Examination of current and emerging targeted therapeutic strategies.

Main Results:

  • Pseudokinases ROR1, PTK7, and RYK play significant roles in regulating cancer cell behaviors.
  • Their involvement in non-canonical Wnt signaling impacts cell survival, migration, and polarization.
  • Progress in understanding pseudokinase signaling provides a basis for therapeutic interventions.

Conclusions:

  • Targeting ROR1, PTK7, and RYK presents a viable therapeutic avenue for hematological malignancies.
  • Further research into their molecular mechanisms can optimize targeted cancer therapies.
  • Understanding pseudokinase signaling is crucial for improving cancer treatment outcomes.
Keywords:
Wnt signalinghematological cancerspseudokinasestargeted therapies

More Related Videos

Modeling Paracrine Noncanonical Wnt Signaling In Vitro11:14

Modeling Paracrine Noncanonical Wnt Signaling In Vitro

Published on: December 10, 2021

1.9K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

54.1K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.0K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K